Shopping Cart (0)
My Account

Shopping Cart
SELECTBIO Conferences miRNA and Non-coding RNA

Emily Wang's Biography



Emily Wang, Assistant Professor, City of Hope Beckman Research Institute

S. Emily Wang, Ph.D., is currently Assistant Professor of Cancer Biology in the Beckman Research Institute of the City of Hope. She first began her research career in the late 1990s as a virologist and obtained her doctorate from University of Nebraska-Lincoln and Nankai University in 2002, followed by a post-doctoral training in viral oncology in the laboratory of Dr. Gary Hayward at the Sidney Kimmel Cancer Center of Johns Hopkins School of Medicine. In late 2003, Dr. Wang started another post-doc tenure in the laboratory of Dr. Carlos Arteaga at the Vanderbilt-Ingram Cancer Center, where she became a committed cancer researcher with a breast cancer focus. During her fellowship at Vanderbilt, Dr. Wang received a K99/R00 Pathway to Independence Award from NIH/NCI for her studies on the crosstalk between TGF-beta and HER2 in breast cancer. She was also awarded the American Association for Cancer Research (AACR) Scholar-in-Training Award. In 2008, Dr. Wang started a tenure-track Assistant Professor position at City of Hope, where she and her laboratory are investigating cellular and molecular mechanisms of oncogenic signaling in breast carcinogenesis. Dr. Wang has approximately 50 publications related to her research in cancer and viral oncology, and was recently awarded the AACR-Breast Cancer Research Foundation Translational Breast Cancer Research Award.

Emily Wang Image

Identify Blood-based microRNA Markers Predicting Breast Cancer Outcome

Friday, 10 May 2013 at 14:15

Add to Calendar ▼2013-05-10 14:15:002013-05-10 15:15:00Europe/LondonIdentify Blood-based microRNA Markers Predicting Breast Cancer OutcomeSELECTBIOenquiries@selectbiosciences.com

Using discovery profiling of circulating small RNAs, we have identified miRNAs associated with the pathological features and clinical outcome of breast cancer. Our group is currently focusing on refining blood-based miRNA markers for breast cancer diagnosis and prognosis, and exploring the functions of cancer-secreted, circulating miRNAs.


Add to Calendar ▼2013-05-09 00:00:002013-05-10 00:00:00Europe/LondonmiRNA and Non-coding RNASELECTBIOenquiries@selectbiosciences.com